Markets:

Overview

News

Currencies

International

Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

14.38 +0.60 (+4.35%)

Streaming Delayed Price Updated: 10:52 AM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead ↗

August 21, 2023

Via Benzinga

Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples ↗

August 17, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company ↗

August 15, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections ↗

August 14, 2023

Via Benzinga

A Preview Of Adaptive Biotechnologies's Earnings ↗

August 01, 2023

Via Benzinga

Adaptive Biotechnologies's Return On Capital Employed Insights ↗

May 11, 2023

Via Benzinga

Adaptive Biotechnologies: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results

August 02, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Trump Advisor Says Ex-President May Skip Initial Republican Presidential Primary Debates ↗

July 11, 2023

Via Benzinga

Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades ↗

July 11, 2023

Via Benzinga

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023

July 10, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Why Shares of Adaptive Biotechnologies Jumped This Week ↗

June 16, 2023

The company could see its first FDA-approved therapy as early as next year.

Via The Motley Fool

Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought ↗

June 02, 2023

There are always stocks to buy if you're Ark Invest's ace stock picker.

Via The Motley Fool

Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer

June 02, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 26, 2023

There are always stocks to buy if you're Ark Invest's ace stock picker.

Via The Motley Fool

Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

May 24, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗

May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

Via InvestorPlace

Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

May 12, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology

May 09, 2023

The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified and characterized through Adaptive’s TCR discovery platform

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2023 Financial Results

May 03, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference

April 25, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline

April 12, 2023

Collaboration will cover existing and future programs to aid in the development and commercialization of investigational medicines for hematologic malignancies

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023

April 06, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 22, 2023

U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference

February 27, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday ↗

February 15, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results

February 14, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 13, 2023

Via Benzinga

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.